{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:22:10Z","timestamp":1789496530532,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s15010-025-02647-0","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:43:14Z","timestamp":1759315394000},"page":"533-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["NDM-5 and siderophore receptor mutations drive high-level cefiderocol resistance in Klebsiella pneumoniae: a case series"],"prefix":"10.1007","volume":"54","author":[{"given":"Michelle H.","family":"Potter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajih","family":"Askar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo F.","family":"Gomez-Abundis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emir","family":"Kobic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2647_CR1","unstructured":"CDC. Antibiotic Resistance Threats in the United States. 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019."},{"key":"2647_CR2","unstructured":"CDC | Antimicrobial Resistance. & Patient Safety Portal [Internet]. Centers for Disease Control and Prevention. 2024 [cited 2024 Dec 27]. Available from: https:\/\/arpsp.cdc.gov\/profile\/arln\/cre?tabsection-487=1%26year-selector=year2019%26year-selector-2=year2023"},{"key":"2647_CR3","unstructured":"AZDHS | Epidemiology & Disease Control. - Healthcare Associated Infection [Internet]. Arizona Department of Health Services. 2019 [cited 2024 Dec 27]. Available from: https:\/\/www.azdhs.gov\/preparedness\/epidemiology-disease-control\/healthcare-associated-infection\/index.php?utm_medium=email%26utm_source=govedelivery#hai-cre"},{"key":"2647_CR4","doi-asserted-by":"crossref","unstructured":"Tamma PD, Heil EL, Justo JA et al. IDSA 2024 guidance on the treatment of antimicrobial resistant gram-negative infections. Clin Infect Dis. 2024:ciae403.","DOI":"10.1093\/cid\/ciae403"},{"issue":"10","key":"2647_CR5","doi-asserted-by":"publisher","first-page":"e0271221","DOI":"10.1128\/spectrum.02712-21","volume":"9","author":"D Shortridge","year":"2022","unstructured":"Shortridge D, Streit JM, Mendes R, et al. In vitro activity of Cefiderocol against U.S. And European gram-negative clinical isolates collected in 2020 as part of the SENTRY antimicrobial surveillance program. Microbiol Spectr. 2022;9(10):e0271221.","journal-title":"Microbiol Spectr"},{"key":"2647_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/antibiotics11060723","volume":"11","author":"S Karakonstantis","year":"2022","unstructured":"Karakonstantis S, Rousaki M, Kritsotakis EI. Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance. Antibiot (Basel). 2022;11:723.","journal-title":"Antibiot (Basel)"},{"key":"2647_CR7","doi-asserted-by":"publisher","first-page":"105052","DOI":"10.1016\/j.idnow.2025.105052","volume":"55","author":"MH Ting","year":"2025","unstructured":"Ting MH, Martens M, Albazzaz H, Wolesensky C, Kobic E. Risk factors for clinical treatment failure regarding carbapenem-resistant enterobacterales in the Southwestern united States. Infect Dis now. 2025;55:105052.","journal-title":"Infect Dis now"},{"key":"2647_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jgar.2021.01.010","volume":"24","author":"M Estabrook","year":"2021","unstructured":"Estabrook M, Kazmierczak KM, Wise M, Arhin FF, Stone GG, Sahm DF. Molecular characterization of clinical isolates of enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012\u20132017. J Glob Antimicrob Resist. 2021;24:316\u201320. https:\/\/doi.org\/10.1016\/j.jgar.2021.01.010.","journal-title":"J Glob Antimicrob Resist"},{"issue":"12","key":"2647_CR9","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/jac\/dkaa345","volume":"75","author":"V Bortolaia","year":"2020","unstructured":"Bortolaia V, Kaas RS, Ruppe E, et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother. 2020;75(12):3491\u2013500.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2647_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2105-10-421","volume":"10","author":"C Camacho","year":"2009","unstructured":"Camacho C, Coulouris G, Avagyan V, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10(1):421.","journal-title":"BMC Bioinformatics"},{"key":"2647_CR11","doi-asserted-by":"crossref","unstructured":"Snyder BM, Anandan S, Madabhushi A et al. Risk factors for acquisition of invasive infections with NDM-1\u2009+\u2009K. pneumoniae. IJID. 2016;45, Supplement 1:116.","DOI":"10.1016\/j.ijid.2016.02.293"},{"key":"2647_CR12","doi-asserted-by":"publisher","first-page":"dlae141","DOI":"10.1093\/jacamr\/dlae141","volume":"6","author":"G Haidar","year":"2024","unstructured":"Haidar G, Kline EG, Ktsios GD, et al. Emergence of high-level aztreonam-avibactam and Cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline. JAC Antimicrob Resist. 2024;6:dlae141.","journal-title":"JAC Antimicrob Resist"},{"key":"2647_CR13","doi-asserted-by":"publisher","first-page":"ofad276","DOI":"10.1093\/ofid\/ofad276","volume":"10","author":"PJ Simner","year":"2023","unstructured":"Simner PJ, Bergman Y, Conzemius R, et al. An NDM-producing Escherichia coli clinical isolate exhibiting resistance to Cefiderocol and the combination of ceftazidime-avibactam and aztreonam: another step toward pan-beta-lactam resistance. Open Forum Infect Dis. 2023;10:ofad276.","journal-title":"Open Forum Infect Dis"},{"key":"2647_CR14","doi-asserted-by":"publisher","first-page":"106508","DOI":"10.1016\/j.ijantimicag.2021.106508","volume":"59","author":"L Wei","year":"2022","unstructured":"Wei L, Feng Y, Wen H, et al. NDM-5-producing carbapenem-resistant Klebsiella pneumoniae of sequence type 789 emerged as a threat for neonates: a multicentre, genome-based study. Int J Antimicrob Agents. 2022;59:106508. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106508.","journal-title":"Int J Antimicrob Agents"},{"key":"2647_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1089\/mdr.2019.0046","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang Z, Li M, Shen X, et al. Outbreak of blaNDM-5-harboring Klebsiella pneumoniae ST290 in a tertiary hospital in China. Microb Drug Resist. 2019;25:1443\u20138.","journal-title":"Microb Drug Resist"},{"key":"2647_CR16","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1093\/jac\/dkae337","volume":"79","author":"C Alvarez","year":"2024","unstructured":"Alvarez C, Nastro M, Goyheneche B, Potente N, Ledesma M, Vay C, Naas T, Foccoli M, de Gregorio S, Famiglietti A, Dabos L, Rodriguez CH. NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina. J Antimicrob Chemother. 2024;79:3174\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"2647_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12866-024-03306-4","volume":"24","author":"A Talat","year":"2024","unstructured":"Talat A, Khan F, Khan A. Genome analysis of colistin-resistant high-risk blaNDM\u20135 producing Klebsiella pneumoniae ST147 and Pseudomonas aeruginosa ST235 and ST357 in clinical settings. BMC Microbiol. 2024;24:174.","journal-title":"BMC Microbiol"},{"key":"2647_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/cid\/ciab457","volume":"73","author":"Z Lapp","year":"2021","unstructured":"Lapp Z, Crawford R, Miles-Jay A, et al. Regional spread of blaNDM-1-containing Klebsiella pneumoniae ST147 in post-acute care facilities. Clin Infect Dis. 2021;73:1431\u201339.","journal-title":"Clin Infect Dis"},{"key":"2647_CR19","doi-asserted-by":"publisher","first-page":"e0008422","DOI":"10.1128\/spectrum.00084-22","volume":"10","author":"P Lan","year":"2022","unstructured":"Lan P, Lu Y, Chem Z, et al. Emergence of high-level Cefiderocol resistance in carbapenem-resistant Klebsiella pneumoniae from bloodstream infections in patients with hematologic malignancies in China. Microbiol Spectr. 2022;10:e0008422.","journal-title":"Microbiol Spectr"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02647-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02647-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02647-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:40:05Z","timestamp":1770021605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02647-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2647"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02647-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the cohort, the ethic committee waived the need of informed consent to publish.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EK has served on the speaker\u2019s bureau member for Shionogi. All other authors report no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Due to the retrospective nature of the cohort, the ethic committee waived the need of informed consent to participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}